Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Portola Pharmaceuticals Inc. (PTLA)

29.48   0.67 (2.33%) 05-23 16:00
Open: 28.87 Pre. Close: 29.08
High: 29.64 Low: 28.53
Volume: 997,492 Market Cap: 2008M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 29.666 - 29.875 29.875 - 30.037
Low: 28.145 - 28.363 28.363 - 28.533
Close: 29.19 - 29.534 29.534 - 29.8

Technical analysis

as of: 2019-05-23 4:27:45 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 39.44     One year: 43.62
Support: Support1: 27.97    Support2: 23.27
Resistance: Resistance1: 33.77    Resistance2: 37.35
Pivot: 31.30
Moving Average: MA(5): 29.10     MA(20): 32.41
MA(100): 30.71     MA(250): 29.75
MACD: MACD(12,26): -1.54     Signal(9): -1.17
Stochastic oscillator: %K(14,3): 12.80     %D(3): 10.26
RSI: RSI(14): 37.30
52-week: High: 45.60  Low: 14.81  Change(%): -26.3
Average Vol(K): 3-Month: 111530  10-Days: 112407

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
PTLA has closed above bottom band by 32.8%. Bollinger Bands are 67.7% wider than normal. The large width of the bands suggest high volatility as compared to PTLA's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 17 May 2019 22:07:17 Z
Portola Pharmaceuticals Enters Oversold Territory (PTLA)

Thu, 09 May 2019 13:58:55 Z
3 Key Takeaways From Portola Pharmaceuticals' Quarterly Results

Wed, 08 May 2019 20:55:27 Z
Noteworthy Wednesday Option Activity: MYL, WYNN, PTLA

Wed, 08 May 2019 20:13:36 Z
Health Care Sector Update for 05/08/2019: BHVN,GHDX,JAZZ,PTLA

Wed, 08 May 2019 20:00:45 Z
Portola Pharmaceuticals Inc (PTLA) Q1 2019 Earnings Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 68.11
Shares Float (M) 67.16
% Held by Insiders
% Held by Institutions
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS -5.010
EPS Est. Current Year -4.820
EPS Est. Next Year -1.820
EPS Est. Next Quarter -1.410
Forward EPS -1.470
Book Value (p.s.) 42.790
PEG Ratio
Profit Margin
Operating Margin -578.60
Return on Assets (ttm) -80.7
Return on Equity (ttm) -209.3
Qtrly Rev. Growth 233.7
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -301.27
Levered Free Cash Flow (M) -157.71

Stock Valuations

P/E -5.88
P/E Growth Ratio 0.02
P/BV 0.69
P/S 2390336768.00
P/CF -6.66

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.